Biodegradable Magnesium Bone Plate and Screw Fixation in Jaw Surgery
MgJawSurgery
Development and Application of Biodegradable Magnesium Bone Plate and Screw Fixation in Jaw Surgery
1 other identifier
interventional
62
0 countries
N/A
Brief Summary
The purpose of this study is to evaluate the efficacy and safety of using high-purity magnesium bone plates and screws for internal fixation in jaw surgery. The investigators aim to assess whether these biodegradable magnesium devices promote normal bone healing and functional recovery while ensuring the safety of patients undergoing dentoalveolar surgery, fracture fixation, orthognathic surgery, or craniofacial reconstruction. The hypotheses are:
- 1.High-purity magnesium bone plates and screws are effective in bone fixation, promoting normal bone healing and functional recovery in jaw surgery.
- 2.High-purity magnesium bone plates and screws are safe in jaw surgery in terms of local side effects and systemic safety.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2024
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 26, 2024
CompletedFirst Posted
Study publicly available on registry
August 5, 2024
CompletedStudy Start
First participant enrolled
August 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 15, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 15, 2028
August 5, 2024
July 1, 2024
3 years
June 26, 2024
July 30, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The efficacy of using high-purity magnesium bone plate and screw fixation in jaw surgery
Efficacy is defined as the rate of successful bone healing and intended functional recovery of the jaw after surgery. Efficacy will be evaluated by clinical assessment and radiological assessment in terms of normal bone healing and functional recovery. Patients will be followed up at 1 week, 3 weeks, 6 weeks, 3 months, 6 months, 1 year, and 2 years after surgery. The occlusal function will be evaluated by the occlusal alignment and the resumption of normal diet. The bone structure will be assessed using plain X-ray immediately after surgery, and at 3 months, 6 months, 1 year, and 2 years post-surgery. CBCT/CT will also be performed to evaluate bone healing and potential complications immediately after surgery (serving as baseline reference), and at 3 months and 1 year after surgery. If CBCT/CT is taken, then plain X-ray will be omitted. The postoperative X-ray schedules represent standard procedures at our center for patients undergoing internal fixation.
1 week - 2 years
Secondary Outcomes (3)
Magnesium degradation
1 week - 2 years
Local side effects
1 week - 2 years
Systemic side effects
1 week - 2 years
Study Arms (1)
Magnesium bone plate and screw fixation in jaw surgery
EXPERIMENTALInterventions
Participants will undergo jaw surgery based on their clinical indications. High-purity magnesium bone plates and screws will be used for internal fixation during the surgical procedure.
Eligibility Criteria
You may qualify if:
- Participants must be 18 years of age or older.
- Participants must have confirmed indications for jaw surgery with internal fixation, such as alveolar onlay bone grafting, fracture fixation, orthognathic surgery, or reconstructive surgery.
- Participants should have adequate bone quality and sufficient bone volume to support the placement of magnesium bone plates and screws.
- Participants must provide written informed consent, indicating their understanding of the potential risks and benefits of magnesium bone plate and screw fixation.
You may not qualify if:
- Participants with certain medical conditions that may affect bone healing or increase the risk of complications, such as uncontrolled diabetes, severe osteoporosis, multiple myelomas, or active bone infections.
- Participants with medical conditions that may exacerbate or predispose them to systemic side effects of magnesium implants, thus contraindicating their use, should be excluded. These conditions include chronic kidney disease, hypermagnesemia, severe electrolyte imbalances, severe heart disease (especially in those with a history of arrhythmias or heart failure), myasthenia gravis, abnormal thyroid functions, hyperparathyroidism, and adrenocortical insufficiency.
- Participants with known allergies or hypersensitivity to magnesium.
- Participants with an ASA score of 3 or above, indicating a higher risk for general anesthesia.
- Participants who are pregnant or breastfeeding.
- Participants deemed unlikely to comply with the study protocol, such as attending follow-up appointments or adhering to post-operative care instructions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yiu Yan Leung
The University of Hong Kong
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor in Oral and Maxillofacial Surgery
Study Record Dates
First Submitted
June 26, 2024
First Posted
August 5, 2024
Study Start
August 15, 2024
Primary Completion (Estimated)
August 15, 2027
Study Completion (Estimated)
August 15, 2028
Last Updated
August 5, 2024
Record last verified: 2024-07